All News

    Saying No to Shapewear After a Double Mastectomy

    June 27th 2025, 5:00pm

    Article

    After having a double mastectomy to rid myself of cancer, I’m less picky about how I look and won’t be wearing uncomfortable shapewear for a wedding.

    FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers

    June 27th 2025, 4:00pm

    Article

    Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and multiple myeloma, respectively.

    CAR T Transforms Treatment Landscape for Blood Cancers

    June 27th 2025, 3:00pm

    Article

    CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, says Dr. André Goy.

    Side Effects of BGB-16673 Appear Manageable in Early CLL Study

    June 27th 2025, 1:00pm

    Video

    An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.

    It’s Me, A Cancer Survivor, I Refuse to Be Ignored

    June 26th 2025, 9:00pm

    Article

    I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who won’t be ignored.

    A Cancer Thriver Breaks Down Her Definition of Survivorship

    June 26th 2025, 8:00pm

    Video

    Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.

    June Blood Cancer Highlights: Top 5 Updates Patients Should Know

    June 26th 2025, 7:00pm

    Article

    June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.

    Making Prostate Cancer Easier to Understand for Those Newly Diagnosed

    June 26th 2025, 5:00pm

    Article

    Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care.

    Caring for Patients With Cancer Beyond Remission

    June 26th 2025, 4:00pm

    Article

    I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and emotional challenges.

    FDA Grants Priority Review to Revuforj for Mutant NPM1 AML

    June 26th 2025, 3:00pm

    Article

    The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.